These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis. Piskunowicz M; Kosiak W; Batko T; Piankowski A; Połczyńska K; Adamkiewicz-Drożyńska E Ultrasound Med Biol; 2015 Apr; 41(4):1095-9. PubMed ID: 25701526 [TBL] [Abstract][Full Text] [Related]
6. Starting a pediatric contrast ultrasound service: made simple! Darge K; Back SJ; Barth RA; Johnson AM; Kwon JK; McCarville MB; Morgan TA; Ntoulia A; Poznick L; Shellikeri S; Srinivasan AS; Cahill AM Pediatr Radiol; 2021 Nov; 51(12):2139-2146. PubMed ID: 33978800 [TBL] [Abstract][Full Text] [Related]
7. Pediatric contrast-enhanced ultrasound in the United States: a survey by the Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology. Back SJ; Maya C; Darge K; Acharya PT; Barnewolt CE; Coleman JL; Dillman JR; Fordham LA; Hwang M; Lim A; McCarville MB; Munden MM; Paltiel HJ; Volberg FM Pediatr Radiol; 2018 Jun; 48(6):852-857. PubMed ID: 29442152 [TBL] [Abstract][Full Text] [Related]
8. Applications of contrast-enhanced ultrasound in the pediatric abdomen. Ntoulia A; Anupindi SA; Darge K; Back SJ Abdom Radiol (NY); 2018 Apr; 43(4):948-959. PubMed ID: 28980061 [TBL] [Abstract][Full Text] [Related]
9. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Darge K; Papadopoulou F; Ntoulia A; Bulas DI; Coley BD; Fordham LA; Paltiel HJ; McCarville B; Volberg FM; Cosgrove DO; Goldberg BB; Wilson SR; Feinstein SB Pediatr Radiol; 2013 Sep; 43(9):1063-73. PubMed ID: 23843130 [TBL] [Abstract][Full Text] [Related]
10. Pediatric contrast-enhanced ultrasound: shedding light on the pursuit of approval in the United States. Darge K; Back SJ; Bulas DI; Feinstein SB; Ntoulia A; Volberg FM; Wilson SR; McCarville MB Pediatr Radiol; 2021 Nov; 51(12):2128-2138. PubMed ID: 34117520 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study. Hyvelin JM; Gaud E; Costa M; Helbert A; Bussat P; Bettinger T; Frinking P J Ultrasound Med; 2017 May; 36(5):941-953. PubMed ID: 28240842 [TBL] [Abstract][Full Text] [Related]
12. Increased Susceptibility for Adverse Reactions to Ultrasound Enhancing Agents in Sickle Cell Disease. Wu M; Fields JJ; Sachdev V; Belcik JT; Chen J; Reed F; Fu X; Hodovan J; Harmann LM; Swistara G; Lindner JR J Am Soc Echocardiogr; 2023 Feb; 36(2):208-215. PubMed ID: 36113741 [TBL] [Abstract][Full Text] [Related]
13. Intravenous application of second-generation ultrasound contrast agents in children: a review of the literature. Piskunowicz M; Kosiak W; Batko T Ultraschall Med; 2012 Apr; 33(2):135-40. PubMed ID: 22161614 [TBL] [Abstract][Full Text] [Related]
14. Safety Analysis of Adverse Events of Ultrasound Contrast Agent Lumason/SonoVue in 49,100 Patients. Li Q; Yang K; Ji Y; Liu H; Fei X; Zhang Y; Li J; Luo Y Ultrasound Med Biol; 2023 Feb; 49(2):454-459. PubMed ID: 36357252 [TBL] [Abstract][Full Text] [Related]
15. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. Wei K; Mulvagh SL; Carson L; Davidoff R; Gabriel R; Grimm RA; Wilson S; Fane L; Herzog CA; Zoghbi WA; Taylor R; Farrar M; Chaudhry FA; Porter TR; Irani W; Lang RM J Am Soc Echocardiogr; 2008 Nov; 21(11):1202-6. PubMed ID: 18848430 [TBL] [Abstract][Full Text] [Related]
16. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC; Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249 [TBL] [Abstract][Full Text] [Related]
17. Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents. Eisenbrey JR; Daecher A; Kramer MR; Forsberg F J Ultrasound Med; 2015 Nov; 34(11):1961-8. PubMed ID: 26384606 [TBL] [Abstract][Full Text] [Related]
18. Magnesium for treating sickle cell disease. Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830 [TBL] [Abstract][Full Text] [Related]
19. Influence of contrast-enhanced ultrasound administration setups on microbubble enhancement: a focus on pediatric applications. Kramer MR; Bhagat N; Back SJ; Poznick L; Forsberg F; Darge K; Eisenbrey JR Pediatr Radiol; 2018 Jan; 48(1):101-108. PubMed ID: 28894889 [TBL] [Abstract][Full Text] [Related]
20. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Jacobson SJ; Kopecky EA; Joshi P; Babul N Lancet; 1997 Nov; 350(9088):1358-61. PubMed ID: 9365450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]